← Back to Search

Auricular Acupressure for Pain

N/A
Recruiting
Led By Michelle Olshan-Perlmutter, PMHCNS-BC
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients requiring admission to psychiatric emergency room who also have documented chronic or acute pain
History of chronic or acute pain with or without opioid use disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 1, day 2, day 3
Awards & highlights

Study Summary

This trial is researching if acupressure applied to the ear can help reduce pain when used alongside standard medication. It will also assess if it should be routinely offered to people with pain and mental health issues.

Who is the study for?
This study is for patients admitted to a psychiatric emergency room who can read and understand consent forms, have stayed or will stay at least 2-3 days, and suffer from chronic or acute pain. It's not for those with cognitive impairments, legal guardians, ear skin diseases, adhesive allergies, recent ear scars/cuts, or certain hearing aids.Check my eligibility
What is being tested?
The trial tests the effects of Auricular Acupressure (acupressure on the outer ear) alongside standard pain medications. The goal is to see if this method reduces pain levels and improves wellbeing when added to usual care for patients with psychiatric diagnoses experiencing pain.See study design
What are the potential side effects?
Potential side effects may include discomfort at the acupressure pad application site on the ear. Since it's non-invasive and used in addition to regular medication, other significant side effects are not commonly expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been to a psychiatric ER and have chronic or acute pain.
Select...
I have a history of chronic or acute pain, with or without opioid use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 1, day 2, day 3
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 1, day 2, day 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient reported pain and general activity scores (Visual Analogue Scale)
Secondary outcome measures
BAA Press placement survey (interventionists only)
Battlefield auricular acupressure (BAA) press Question 1
Battlefield auricular acupressure (BAA) press question 2
+3 more
Other outcome measures
Battlefield auricular acupressure (BAA) press question 3

Trial Design

1Treatment groups
Experimental Treatment
Group I: Auricular Acupressure Pad GroupExperimental Treatment1 Intervention
All subjects who qualify and agree to be in the study will be given Auricular Acupressure using an acupressure pad containing acupressure seeds for 4 days in addition to their regular standard of care pain medication.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,243 Previous Clinical Trials
1,004,710 Total Patients Enrolled
22 Trials studying Pain
2,437 Patients Enrolled for Pain
Michelle Olshan-Perlmutter, PMHCNS-BCPrincipal InvestigatorWake Forest University Health Sciences

Media Library

Auricular Acupressure Pad Group Clinical Trial Eligibility Overview. Trial Name: NCT05939388 — N/A
Pain Research Study Groups: Auricular Acupressure Pad Group
Pain Clinical Trial 2023: Auricular Acupressure Pad Group Highlights & Side Effects. Trial Name: NCT05939388 — N/A
Auricular Acupressure Pad Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05939388 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities available for test subjects to participate in this research?

"Per data on clinicaltrials.gov, this medical investigation is not actively recruiting patients at the moment. The trial was initially posted in July 1st 2023 and last updated three days later. However, there are still 520 other trials currently accepting enrollees for their studies."

Answered by AI
~7 spots leftby Aug 2024